Corneal Topographers Market Set to Witness an Uptick during 2020 to 2027

Posted by Mrudula Anil Karmarkar on April 12th, 2022

The global corneal topographers market size is expected to reach USD 915.6 million by the end of 2027, expanding at a CAGR of 4.8%, according to a new report by Grand View Research, Inc. Increasing incidence of ophthalmic disorders including cataract and diabetic retinopathy is expected to accelerate market growth. According to the Centers of Disease Control and Prevention (CDC), 2015, 20.5 million Americans were cataract patients, out of which, 6.1 million people underwent cataract surgery. CDC further stated that the patient population suffering from cataracts is estimated to escalate to 30.1 million by 2020.

Growing efforts of government organizations to increase awareness and reach an effective ophthalmic care through ambulatory centers are expected to bolster market growth. For instance, the International Agency for the Prevention of Blindness (IAPB) and the World Health Organization (WHO) launched an initiative named Right to Sight, intending to eliminate preventable vision loss in patients suffering from various eye conditions.           

Frequent new product approval is expected to aid corneal topographers market growth during the forecast period. For instance, in January 2017, the U.S. FDA approved Aladdin corneal topographer HW3.0 developed by Topcon Medical Systems for distribution in U.S. The new version includes features such as central pachymetry, toric IOL calculator, thereby allowing precision diagnosis.

Major factors driving the market for corneal topographers include increasing prevalence and incidence of age-associated ophthalmic conditions coupled with the rising number of government initiatives to create awareness for early detection, prevention, and treatment of these conditions. For instance, in July 2016, the Indian State government under the coverage of Rashtriya Swasthya Bima Yojna (RSBY) offered free eye surgeries at state medical colleges and hospitals. This led to steep growth in ophthalmic surgery volume in the country. Moreover, increasing focus of market players on research and development and high engagement in strategic collaborations to develop innovative ophthalmic diagnostic modalities are the factors expected to be affirmative growth indicators. However, post-surgical complications caused due to ophthalmic interventions are expected to restrain the growth of the market for corneal topographers.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/corneal-topographers-market/request/rs1

The integration of novel diagnostic modalities for screening and early detection of ophthalmic conditions including cataracts is expected to bolster the demand for corneal topographers. According to the facts stated by the World Health Organization, October 2020, around 2.2 billion people were affected with vision impairment or blindness worldwide, of which at least 1 billion people had unaddressed or preventable conditions.

Further key findings from the report suggest:

• North America accounted for the largest share in 2020 owing to increasing awareness initiatives led by various organizations, increasing prevalence of preventable vision loss, increasing product approvals combined with higher adoption of innovative ophthalmic diagnostic systems in the medical settings
• The placido disc system segment dominated the market owing to its high usage in hospital settings with advantages such as effective anterior eye screening capabilities and availability
• By application, the refractive surgery evaluation segment is expected to register the highest CAGR as corneal topographers are common diagnostic tools for measurement of refractive error
• By end use, the hospital segment accounted for the largest corneal topographers market share as an increasing number of hospital settings are equipped with technologically advanced systems for conducting ophthalmic surgeries
• The leading players present in the market include Carl Zeiss AG, EyeSys Vision, Cassini Technologies, Nidek Co., Ltd., OCULUS Optikgeräte GmbH, Tomey Corporation, Tracey Technologies, and Topcon Corporation

The Vision Loss Expert Group, in 2017 stated that blindness or vision impairment was majorly due to refractive error- 12%, cataract 6.3%, glaucoma (0.7%), corneal opacities (0.4%), diabetic retinopathy 0.3%, and trachoma 0.2%. Presbyopia accounted for 80.1% of the total unaddressed cases.

Furthermore, increasing the volume of surgical procedures in different healthcare settings including hospitals, clinics, and ambulatory care centers is expected to augment the demand for advanced corneal topographers. According to the survey undertaken by Refractive Surgery Council, around 843,000 vision correction procedures such as LASIK, PRK, and SMILE were performed in the U.S. in 2018, representing an overall increase of 6.2% as compared to 2017.

The leading players present in the market for corneal topographers include Carl Zeiss AG, OCULUS Optikgeräte GmbH, Cassini Technologies, Nidek Co., Ltd., Tomey Corporation, EyeSys Vision, Tracey Technologies, and Topcon Corporation.